首页 > 市场调查报告书 > 食物/饮料

市场调查报告书

商品编码

1470730

超重治疗市场：依产品类型、最终用户、地区 - 全球产业分析、规模、占有率、成长、趋势、预测，2024-2031 年

Overweight Treatment Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

出版日期: 2024年04月24日 | 出版商:

Persistence Market Research | 英文 245 Pages | 商品交期: 2-5个工作天内

价格

简介目录

对全球超重治疗市场的全面分析提供了对其成长动力、课题和新兴趋势的见解。这份详细的报告提供了独特的数据和统计数据来预测 2024 年至 2031 年的市场轨迹。

重要见解

市场规模（2024年）：412亿美元
预计市值（2031 年）：741 亿美元
全球市场成长率（2024-2031年复合年增长率）：7.8%

超重治疗市场 – 研究范围

超重治疗市场解决了全世界对肥胖和超重状况日益关注的问题，提供各种治疗介入、生活方式改变和外科手术来改善体重管理和整体健康。随着久坐生活方式、不健康饮食习惯和代谢异常的增加，肥胖已成为全球流行病，增加了对有效治疗解决方案的需求。该市场包括药品、医疗器材、外科手术以及旨在体重管理和预防肥胖的生活方式干预措施。

市场成长动力：

肥胖和超重的盛行率日益增加，以及人们对超重相关健康风险的认识不断增强，推动了全球对超重治疗解决方案的需求。不良饮食、缺乏运动和压力等生活方式习惯导致肥胖流行，从而促使体重管理疗法和干预措施的市场不断增长。此外，旨在预防和治疗肥胖的政府措施、公共卫生运动和报销政策进一步刺激了市场成长。

市场限制：

儘管人们对超重治疗解决方案的认识和需求不断增加，但一些课题阻碍了市场的成长。其中包括服务欠缺地区获得医疗保健服务的机会有限、肥胖盛行率的社会经济差异以及采取健康生活方式的文化障碍。此外，围绕肥胖的耻辱以及认为体重管理是美容问题而不是医疗问题的观念给医疗保健提供者和政策制定者有效解决肥胖流行问题带来了课题。

市场机会：

超重治疗不断发展的格局为医疗保健、製药、营养和健身等多个领域的创新和合作提供了机会。医疗技术的进步将注意力集中在个人化的体重管理方法上，将遗传、代谢和行为因素纳入治疗策略。此外，数位健康解决方案、穿戴式装置和远距医疗平台的整合正在增强肥胖管理计画的可近性和参与度，为市场扩张创造新的机会。

本报告解决的关键问题

推动超重治疗市场成长的关键因素是什么？
科技进步如何形塑肥胖管理和减重干预措施？
阻碍市场成长的主要课题是什么？
哪些地区的超重治疗市场预计将显着成长？
谁是主要市场利害关係人？

竞争资讯与经营策略：

超重治疗市场的领导者专注于创新、研究和策略联盟，以应对肥胖管理的复杂课题。製药公司将投资开发与肥胖相关的代谢紊乱的新疗法，医疗设备製造商将引进用于微创减肥手术的先进设备。此外，医疗保健提供者与健康组织、营养师和健身专家合作，提供适合个人需求的全面体重管理计划。

主要公司简介：

Novo Nordisk A/S
Roche Holding AG
GlaxoSmithKline plc
Medtronic plc
Johnson & Johnson Services, Inc.
Allergan plc
Abbott Laboratories
Pfizer Inc.
Amgen Inc.
Merck & Co., Inc.

超重治疗市场研究细分：

依治疗分类的超重治疗市场

药物治疗
安非他酮和纳曲酮
奥利司他
芬特明和托□酯
利拉鲁□
其他
补充
医疗器材/植入物
胃气球
胃束带
装订设备

超重治疗市场：依分销管道分类

设施销售
医院
专科诊所
门诊手术中心
零售销售
零售药店
药店
超市/大卖场
保健美容店
网上销售

依地区划分的超重治疗市场

北美
欧洲
亚太地区
拉丁美洲
中东/非洲

比赛仪表板
竞争标桿
衝突详情
- Novo Nordisk A/S
- VIVUS LLC
- AstraZeneca
- Currax Pharmaceuticals LLC.
- Spansules Pharmatech Pvt Ltd
- Atkins Nutritional Inc.
- Apollo Endosurgery, Inc.
- Herbalife Nutrition Ltd.
- SMP Nutra
- Allurion Technologies
- ReShape Lifesciences, Inc.
- Bariatric Solutions GmbH
- Silimed
- ENDALIS
- Districlass Medical
- Medtronic

第 20 章假设与缩写

第21章研究方法论

简介目录

Product Code: PMRREP33086

Persistence Market Research presents a comprehensive analysis of the global overweight treatment market, providing insights into its growth drivers, challenges, and emerging trends. This detailed report offers exclusive data and statistics projecting the market's trajectory from 2024 to 2031.

Key Insights:

Market Size (2024E): US$41.2 Billion
Projected Market Value (2031F): US$74.1 Billion
Global Market Growth Rate (CAGR 2024 to 2031): 7.8%

Overweight Treatment Market - Report Scope:

The overweight treatment market addresses the growing concern of obesity and overweight conditions worldwide, offering various therapeutic interventions, lifestyle modifications, and surgical procedures to manage weight and improve overall health. With the rise in sedentary lifestyles, unhealthy dietary habits, and metabolic disorders, obesity has become a global epidemic, driving demand for effective treatment solutions. The market encompasses pharmaceuticals, medical devices, surgical procedures, and lifestyle interventions aimed at weight management and obesity prevention.

Market Growth Drivers:

The increasing prevalence of obesity and overweight conditions, coupled with rising awareness about the health risks associated with excess weight, drives the demand for overweight treatment solutions globally. Lifestyle factors such as poor diet, lack of physical activity, and stress contribute to the obesity epidemic, creating a growing market for weight management therapies and interventions. Additionally, government initiatives, public health campaigns, and reimbursement policies aimed at obesity prevention and treatment further stimulate market growth.

Market Restraints:

Despite the growing awareness and demand for overweight treatment solutions, several challenges hinder market growth. These include limited access to healthcare services in underserved regions, socioeconomic disparities in obesity prevalence, and cultural barriers to adopting healthy lifestyles. Moreover, the stigma associated with obesity and the perception of weight management as a cosmetic issue rather than a medical concern pose challenges for healthcare providers and policymakers in addressing the obesity epidemic effectively.

Market Opportunities:

The evolving landscape of overweight treatment presents opportunities for innovation and collaboration across various sectors, including healthcare, pharmaceuticals, nutrition, and fitness. With advancements in medical technology, there is a growing focus on personalized approaches to weight management, incorporating genetic, metabolic, and behavioral factors into treatment strategies. Furthermore, the integration of digital health solutions, wearable devices, and telemedicine platforms enhances accessibility and engagement in obesity management programs, creating new opportunities for market expansion.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the overweight treatment market?
How are technological advancements shaping the landscape of obesity management and weight loss interventions?
What are the key challenges hindering market growth, and how can they be addressed?
Which regions are expected to witness significant growth in the overweight treatment market?
Who are the key stakeholders in the market, and what strategies are they adopting to address the obesity epidemic?

Competitive Intelligence and Business Strategy:

Leading players in the overweight treatment market focus on innovation, research, and strategic partnerships to address the complex challenges of obesity management. Pharmaceutical companies invest in the development of novel therapeutics targeting obesity-related metabolic disorders, while medical device manufacturers introduce advanced devices for minimally invasive weight loss procedures. Moreover, healthcare providers collaborate with wellness organizations, nutritionists, and fitness professionals to offer comprehensive weight management programs tailored to individual needs.

Key Companies Profiled:

Novo Nordisk A/S
Roche Holding AG
GlaxoSmithKline plc
Medtronic plc
Johnson & Johnson Services, Inc.
Allergan plc
Abbott Laboratories
Pfizer Inc.
Amgen Inc.
Merck & Co., Inc.

Overweight Treatment Market Research Segmentation:

Overweight Treatment Market by Treatment:

Drug Treatment
Bupropion and Naltrexone
Orlistat
Phentermine and Topiramate
Liraglutide
Others
Supplements
Medical Devices / Implants
Gastric Balloons
Gastric Bands
Stapling Devices

Overweight Treatment Market by Distribution Channel:

Institutional Sales
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Retail Sales
Retail Pharmacy
Drug Stores
Supermarkets / Hypermarkets
Health & Beauty Stores
Online Sales

Overweight Treatment Market by Region:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Innovation / Development Trends

4. Key Success Factors

4.1. Product Adoption Analysis
4.2. Obesity Rate by Country
4.3. Obesity Drugs Pipeline Analysis
4.4. Obesity Drug Withdrawal Analysis
4.5. Obesity Drug / Device Withdrawal, Termination from Clinical Trials
4.6. Regulatory Scenario
4.7. Key Promotional Strategies by Manufacturers
4.8. Porter's Analysis
4.9. PESTEL Analysis

5. COVID19 Crisis Analysis

5.1. Current COVID19 Statistics and Probable Future Impact
5.2. Current GDP Projection and Probable Impact
5.3. Current Economic Projection as compared to 2008 Economic analysis
5.4. COVID-19 and Impact Analysis
- 5.4.1. Revenue by Treatment
- 5.4.2. Revenue by Distribution Channel
- 5.4.3. Revenue by Country

6. Market Background

6.1. Macro-Economic Factors
- 6.1.1. Global GDP Growth Outlook
- 6.1.2. Per-Capita Healthcare Expenditure
6.2. Forecast Factors - Relevance & Impact
- 6.2.1. COVID-19 Pandemic
- 6.2.2. Increasing Prevalence of Obesity
- 6.2.3. Rise in R&D Investments
- 6.2.4. Top Overweight Treatment Companies and Their Historical Growth
- 6.2.5. Rise in Number of Clinical Studies
- 6.2.6. Increasing Investment in Obesity Research
- 6.2.7. GDP Growth
- 6.2.8. Adoption Rate of Overweight Treatment Products
6.3. Market Dynamics
- 6.3.1. Drivers
- 6.3.2. Restraints
- 6.3.3. Opportunity Analysis

7. Global Overweight Treatment Market Demand (in Value or Size in US$ MN) Analysis 2019-2023 and Forecast, 2024-2031

7.1. Historical Market Value (US$ MN) Analysis, 2019-2023
7.2. Current and Future Market Value (US$ MN) Projections, 2024-2031
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis

8. Global Overweight Treatment Market Analysis 2019-2023 and Forecast 2024-2031, by Treatment

8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis by Treatment, 2019-2023
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Treatment, 2024-2031
- 8.3.1. Drug Treatment
  - 8.3.1.1. Bupropion and Naltrexone
  - 8.3.1.2. Orlistat
  - 8.3.1.3. Phentermine and Topiramate
  - 8.3.1.4. Liraglutide
  - 8.3.1.5. Others
- 8.3.2. Supplements
- 8.3.3. Medical Devices / Implants
  - 8.3.3.1. Gastric Balloons
  - 8.3.3.2. Gastric Bands
  - 8.3.3.3. Stapling Devices
8.4. Market Attractiveness Analysis by Treatment

9. Global Overweight Treatment Market Analysis 2019-2023 and Forecast 2024-2031, by Distribution Channel

9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis by Distribution Channel, 2019-2023
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Distribution Channel, 2024-2031
- 9.3.1. Institutional Sales
  - 9.3.1.1. Hospitals
  - 9.3.1.2. Specialty Clinics
  - 9.3.1.3. Ambulatory Surgical Centers
- 9.3.2. Retail Sales
  - 9.3.2.1. Retail Pharmacy
  - 9.3.2.2. Drug Stores
  - 9.3.2.3. Supermarkets/ Hypermarkets
  - 9.3.2.4. Health & Beauty Stores
- 9.3.3. Online Sales
9.4. Market Attractiveness Analysis by Distribution Channel

10. Global Overweight Treatment Market Analysis 2019-2023 and Forecast 2024-2031, by Region

10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2023
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Region, 2024-2031
- 10.3.1. North America
- 10.3.2. Latin America
- 10.3.3. Europe
- 10.3.4. East Asia
- 10.3.5. South Asia
- 10.3.6. Oceania
- 10.3.7. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region

11. North America Overweight Treatment Market Analysis 2019-2023 and Forecast 2024-2031

11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2019-2023
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2031
- 11.3.1. By Country
  - 11.3.1.1. U.S.
  - 11.3.1.2. Canada
- 11.3.2. By Treatment
- 11.3.3. By Distribution Channel
11.4. Market Attractiveness Analysis
- 11.4.1. By Country
- 11.4.2. By Treatment
- 11.4.3. By Distribution Channel
11.5. Market Trends
11.6. Key Market Participants - Intensity Mapping
11.7. Drivers and Restraints - Impact Analysis
11.8. Country Level Analysis & Forecast
- 11.8.1. U.S. Overweight Treatment Market Analysis
  - 11.8.1.1. Introduction
  - 11.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 11.8.1.2.1. By Treatment
    - 11.8.1.2.2. By Distribution Channel
- 11.8.2. Canada Overweight Treatment Market Analysis
  - 11.8.2.1. Introduction
  - 11.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 11.8.2.2.1. By Treatment
    - 11.8.2.2.2. By Distribution Channel

12. Latin America Overweight Treatment Market Analysis 2019-2023 and Forecast 2024-2031

12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2019-2023
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2031
- 12.3.1. By Country
  - 12.3.1.1. Mexico
  - 12.3.1.2. Brazil
  - 12.3.1.3. Argentina
  - 12.3.1.4. Rest of Latin America
    - 12.3.1.4.1. By Treatment
    - 12.3.1.4.2. By Distribution Channel
12.4. Market Attractiveness Analysis
- 12.4.1. By Country
- 12.4.2. By Treatment
- 12.4.3. By Distribution Channel
12.5. Market Trends
12.6. Key Market Participants - Intensity Mapping
12.7. Drivers and Restraints - Impact Analysis
12.8. Country Level Analysis & Forecast
- 12.8.1. Mexico Overweight Treatment Market Analysis
  - 12.8.1.1. Introduction
  - 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 12.8.1.2.1. By Treatment
    - 12.8.1.2.2. By Distribution Channel
- 12.8.2. Brazil Overweight Treatment Market Analysis
  - 12.8.2.1. Introduction
  - 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 12.8.2.2.1. By Treatment
    - 12.8.2.2.2. By Distribution Channel
- 12.8.3. Argentina Overweight Treatment Market Analysis
  - 12.8.3.1. Introduction
  - 12.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 12.8.3.2.1. By Treatment
    - 12.8.3.2.2. By Distribution Channel

13. Europe Overweight Treatment Market Analysis 2019-2023 and Forecast 2024-2031

13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2019-2023
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2031
- 13.3.1. By Country
  - 13.3.1.1. Germany
  - 13.3.1.2. Italy
  - 13.3.1.3. France
  - 13.3.1.4. U.K.
  - 13.3.1.5. Spain
  - 13.3.1.6. BENELUX
  - 13.3.1.7. Nordic Countries & Russia
  - 13.3.1.8. Rest of Europe
- 13.3.2. By Treatment
- 13.3.3. By Distribution Channel
13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Treatment
- 13.4.3. By Distribution Channel
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis & Forecast
- 13.8.1. Germany Overweight Treatment Market Analysis
  - 13.8.1.1. Introduction
  - 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.1.2.1. By Treatment
    - 13.8.1.2.2. By Distribution Channel
- 13.8.2. Italy Overweight Treatment Market Analysis
  - 13.8.2.1. Introduction
  - 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.2.2.1. By Treatment
    - 13.8.2.2.2. By Distribution Channel
- 13.8.3. France Overweight Treatment Market Analysis
  - 13.8.3.1. Introduction
  - 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.3.2.1. By Treatment
    - 13.8.3.2.2. By Distribution Channel
- 13.8.4. U.K. Overweight Treatment Market Analysis
  - 13.8.4.1. Introduction
  - 13.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.4.2.1. By Treatment
    - 13.8.4.2.2. By Distribution Channel
- 13.8.5. Spain Overweight Treatment Market Analysis
  - 13.8.5.1. Introduction
  - 13.8.5.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.5.2.1. By Treatment
    - 13.8.5.2.2. By Distribution Channel
- 13.8.6. BENELUX Overweight Treatment Market Analysis
  - 13.8.6.1. Introduction
  - 13.8.6.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.6.2.1. By Treatment
    - 13.8.6.2.2. By Distribution Channel
- 13.8.7. Nordic Countries & Russia Overweight Treatment Market Analysis
  - 13.8.7.1. Introduction
  - 13.8.7.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.7.2.1. By Treatment
    - 13.8.7.2.2. By Distribution Channel

14. East Asia Overweight Treatment Market Analysis 2019-2023 and Forecast 2024-2031

14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2019-2023
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2031
- 14.3.1. By Country
  - 14.3.1.1. China
  - 14.3.1.2. Japan
  - 14.3.1.3. South Korea
    - 14.3.1.3.1. By Treatment
    - 14.3.1.3.2. By Distribution Channel
14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Treatment
- 14.4.3. By Distribution Channel
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
- 14.8.1. China Overweight Treatment Market Analysis
  - 14.8.1.1. Introduction
  - 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.1.2.1. By Treatment
    - 14.8.1.2.2. By Distribution Channel
- 14.8.2. Japan Overweight Treatment Market Analysis
  - 14.8.2.1. Introduction
  - 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.2.2.1. By Treatment
    - 14.8.2.2.2. By Distribution Channel
- 14.8.3. South Korea Overweight Treatment Market Analysis
  - 14.8.3.1. Introduction
  - 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.3.2.1. By Treatment
    - 14.8.3.2.2. By Distribution Channel

15. South Asia Overweight Treatment Market Analysis 2019-2023 and Forecast 2024-2031

15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2019-2023
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2031
- 15.3.1. By Country
  - 15.3.1.1. India
  - 15.3.1.2. Indonesia
  - 15.3.1.3. Malaysia
  - 15.3.1.4. Philippines
  - 15.3.1.5. Thailand
  - 15.3.1.6. Vietnam
  - 15.3.1.7. Rest of South Asia
- 15.3.2. By Treatment
- 15.3.3. By Distribution Channel
15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Treatment
- 15.4.3. By Distribution Channel
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
- 15.8.1. India Overweight Treatment Market Analysis
  - 15.8.1.1. Introduction
  - 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.1.2.1. By Treatment
    - 15.8.1.2.2. By Distribution Channel
- 15.8.2. Indonesia Overweight Treatment Market Analysis
  - 15.8.2.1. Introduction
  - 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.2.2.1. By Treatment
    - 15.8.2.2.2. By Distribution Channel
- 15.8.3. Malaysia Overweight Treatment Market Analysis
  - 15.8.3.1. Introduction
  - 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.3.2.1. By Treatment
    - 15.8.3.2.2. By Distribution Channel
- 15.8.4. Philippines Overweight Treatment Market Analysis
  - 15.8.4.1. Introduction
  - 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.4.2.1. By Treatment
    - 15.8.4.2.2. By Distribution Channel
- 15.8.5. Thailand Overweight Treatment Market Analysis
  - 15.8.5.1. Introduction
  - 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.5.2.1. By Treatment
    - 15.8.5.2.2. By Distribution Channel
- 15.8.6. Vietnam Overweight Treatment Market Analysis
  - 15.8.6.1. Introduction
  - 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.6.2.1. By Treatment
    - 15.8.6.2.2. By Distribution Channel

16. Oceania Overweight Treatment Market 2019-2023 and Forecast 2024-2031

16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2019-2023
16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2031
- 16.3.1. By Country
  - 16.3.1.1. Australia
  - 16.3.1.2. New Zealand
- 16.3.2. By Treatment
- 16.3.3. By Distribution Channel
16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Treatment
- 16.4.3. By Distribution Channel
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
- 16.8.1. Australia Overweight Treatment Market Analysis
  - 16.8.1.1. Introduction
  - 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.1.2.1. By Treatment
    - 16.8.1.2.2. By Distribution Channel
- 16.8.2. New Zealand Overweight Treatment Market Analysis
  - 16.8.2.1. Introduction
  - 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.2.2.1. By Treatment
    - 16.8.2.2.2. By Distribution Channel

17. Middle East and Africa (MEA) Overweight Treatment Market Analysis 2019-2023 and Forecast 2024-2031

17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2019-2023
17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2031
- 17.3.1. By Country
  - 17.3.1.1. GCC Countries
  - 17.3.1.2. Israel
  - 17.3.1.3. Turkey
  - 17.3.1.4. South Africa & North Africa
  - 17.3.1.5. Rest of Middle East and Africa
- 17.3.2. By Treatment
- 17.3.3. By Distribution Channel
17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Treatment
- 17.4.3. By Distribution Channel
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis & Forecast
- 17.8.1. GCC Countries Overweight Treatment Market Analysis
  - 17.8.1.1. Introduction
  - 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.1.2.1. By Treatment
    - 17.8.1.2.2. By Distribution Channel
- 17.8.2. Israel Overweight Treatment Market Analysis
  - 17.8.2.1. Introduction
  - 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.2.2.1. By Treatment
    - 17.8.2.2.2. By Distribution Channel
- 17.8.3. Turkey Overweight Treatment Market Analysis
  - 17.8.3.1. Introduction
  - 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.3.2.1. By Treatment
    - 17.8.3.2.2. By Distribution Channel
- 17.8.4. South Africa & North Africa Overweight Treatment Market Analysis
  - 17.8.4.1. Introduction
  - 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.4.2.1. By Treatment
    - 17.8.4.2.2. By Distribution Channel

18. Market Structure Analysis

18.1. Market Analysis by Tier of Companies
18.2. Market Share Analysis of Top Players
18.3. Market Presence Analysis
- 18.3.1. Regional footprint of Players
- 18.3.2. Channel Foot Print by Players

19. Competition Analysis

19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
- 19.3.1. Novo Nordisk A/S
  - 19.3.1.1. Overview
  - 19.3.1.2. Product Portfolio
  - 19.3.1.3. Key Financials by Market Segments (Product/Channel/Region)
  - 19.3.1.4. Sales Footprint
  - 19.3.1.5. Strategy Overview
  - 19.3.1.6. SWOT Analysis
- 19.3.2. VIVUS LLC
  - 19.3.2.1. Overview
  - 19.3.2.2. Product Portfolio
  - 19.3.2.3. Key Financials by Market Segments (Product/Channel/Region)
  - 19.3.2.4. Sales Footprint
  - 19.3.2.5. Strategy Overview
  - 19.3.2.6. SWOT Analysis
- 19.3.3. AstraZeneca
  - 19.3.3.1. Overview
  - 19.3.3.2. Product Portfolio
  - 19.3.3.3. Key Financials by Market Segments (Product/Channel/Region)
  - 19.3.3.4. Sales Footprint
  - 19.3.3.5. Strategy Overview
  - 19.3.3.6. SWOT Analysis
- 19.3.4. Currax Pharmaceuticals LLC.
  - 19.3.4.1. Overview
  - 19.3.4.2. Product Portfolio
  - 19.3.4.3. Key Financials by Market Segments (Product/Channel/Region)
  - 19.3.4.4. Sales Footprint
  - 19.3.4.5. Strategy Overview
  - 19.3.4.6. SWOT Analysis
- 19.3.5. Spansules Pharmatech Pvt Ltd
  - 19.3.5.1. Overview
  - 19.3.5.2. Product Portfolio
  - 19.3.5.3. Key Financials by Market Segments (Product/Channel/Region)
  - 19.3.5.4. Sales Footprint
  - 19.3.5.5. Strategy Overview
  - 19.3.5.6. SWOT Analysis
- 19.3.6. Atkins Nutritional Inc.
  - 19.3.6.1. Overview
  - 19.3.6.2. Product Portfolio
  - 19.3.6.3. Key Financials by Market Segments (Product/Channel/Region)
  - 19.3.6.4. Sales Footprint
  - 19.3.6.5. Strategy Overview
  - 19.3.6.6. SWOT Analysis
- 19.3.7. Apollo Endosurgery, Inc.
  - 19.3.7.1. Overview
  - 19.3.7.2. Product Portfolio
  - 19.3.7.3. Key Financials by Market Segments (Product/Channel/Region)
  - 19.3.7.4. Sales Footprint
  - 19.3.7.5. Strategy Overview
  - 19.3.7.6. SWOT Analysis
- 19.3.8. Herbalife Nutrition Ltd.
  - 19.3.8.1. Overview
  - 19.3.8.2. Product Portfolio
  - 19.3.8.3. Key Financials by Market Segments (Product/Channel/Region)
  - 19.3.8.4. Sales Footprint
  - 19.3.8.5. Strategy Overview
  - 19.3.8.6. SWOT Analysis
- 19.3.9. SMP Nutra
  - 19.3.9.1. Overview
  - 19.3.9.2. Product Portfolio
  - 19.3.9.3. Key Financials by Market Segments (Product/Channel/Region)
  - 19.3.9.4. Sales Footprint
  - 19.3.9.5. Strategy Overview
  - 19.3.9.6. SWOT Analysis
- 19.3.10. Allurion Technologies
  - 19.3.10.1. Overview
  - 19.3.10.2. Product Portfolio
  - 19.3.10.3. Key Financials by Market Segments (Product/Channel/Region)
  - 19.3.10.4. Sales Footprint
  - 19.3.10.5. Strategy Overview
  - 19.3.10.6. SWOT Analysis
- 19.3.11. ReShape Lifesciences, Inc.
  - 19.3.11.1. Overview
  - 19.3.11.2. Product Portfolio
  - 19.3.11.3. Key Financials by Market Segments (Product/Channel/Region)
  - 19.3.11.4. Sales Footprint
  - 19.3.11.5. Strategy Overview
  - 19.3.11.6. SWOT Analysis
- 19.3.12. Bariatric Solutions GmbH
  - 19.3.12.1. Overview
  - 19.3.12.2. Product Portfolio
  - 19.3.12.3. Key Financials by Market Segments (Product/Channel/Region)
  - 19.3.12.4. Sales Footprint
  - 19.3.12.5. Strategy Overview
  - 19.3.12.6. SWOT Analysis
- 19.3.13. Silimed
  - 19.3.13.1. Overview
  - 19.3.13.2. Product Portfolio
  - 19.3.13.3. Key Financials by Market Segments (Product/Channel/Region)
  - 19.3.13.4. Sales Footprint
  - 19.3.13.5. Strategy Overview
  - 19.3.13.6. SWOT Analysis
- 19.3.14. ENDALIS
  - 19.3.14.1. Overview
  - 19.3.14.2. Product Portfolio
  - 19.3.14.3. Key Financials by Market Segments (Product/Channel/Region)
  - 19.3.14.4. Sales Footprint
  - 19.3.14.5. Strategy Overview
  - 19.3.14.6. SWOT Analysis
- 19.3.15. Districlass Medical
  - 19.3.15.1. Overview
  - 19.3.15.2. Product Portfolio
  - 19.3.15.3. Key Financials by Market Segments (Product/Channel/Region)
  - 19.3.15.4. Sales Footprint
  - 19.3.15.5. Strategy Overview
  - 19.3.15.6. SWOT Analysis
- 19.3.16. Medtronic
  - 19.3.16.1. Overview
  - 19.3.16.2. Product Portfolio
  - 19.3.16.3. Key Financials by Market Segments (Product/Channel/Region)
  - 19.3.16.4. Sales Footprint
  - 19.3.16.5. Strategy Overview
  - 19.3.16.6. SWOT Analysis

20. Assumptions and Acronyms Used

21. Research Methodology

02-2729-4219

+886-2-2729-4219

License/价格

超重治疗市场：依产品类型、最终用户、地区 - 全球产业分析、规模、占有率、成长、趋势、预测，2024-2031 年

Overweight Treatment Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

目录

第一章内容提要

第二章市场概况

第 3 章主要市场趋势

第 4 章关键成功因素

第 5 章 COVID-19 危机分析

第六章市场背景

第七章 全球超重治疗市场需求分析（2019-2023）及预测（2024-2031）

第八章全球超重治疗市场分析（2019-2023）和预测（2024-2031）：依治疗分类

第9章全球超重治疗市场分析（2019-2023）与预测（2024-2031）：依通路

第10章全球超重治疗市场分析（2019-2023）与预测（2024-2031）：依地区

第十一章北美超重治疗市场分析（2019-2023）与预测（2024-2031）

第十二章拉丁美洲超重治疗市场分析（2019-2023）与预测（2024-2031）

第十三章欧洲超重治疗市场分析（2019-2023）与预测（2024-2031）

第十四章东亚超重治疗市场分析（2019-2023）与预测（2024-2031）

第十五章南亚超重治疗市场分析（2019-2023）与预测（2024-2031）

第十六章大洋洲超重治疗市场分析（2019-2023）与预测（2024-2031）

第十七章中东和非洲超重治疗市场分析（2019-2023）和预测（2024-2031）

第18章市场结构分析

第 19 章 竞争分析